Moneta Group Investment Advisors LLC Biogen Inc. Transaction History
Moneta Group Investment Advisors LLC
- $9.24 Billion
- Q3 2024
A detailed history of Moneta Group Investment Advisors LLC transactions in Biogen Inc. stock. As of the latest transaction made, Moneta Group Investment Advisors LLC holds 1,291 shares of BIIB stock, worth $188,744. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1,291Holding current value
$188,744% of portfolio
0.0%Shares
12 transactions
Others Institutions Holding BIIB
# of Institutions
1,006Shares Held
129MCall Options Held
1.12MPut Options Held
1.43M-
Vanguard Group Inc Valley Forge, PA16.7MShares$2.44 Billion0.06% of portfolio
-
Primecap Management CO Pasadena, CA16.3MShares$2.39 Billion2.37% of portfolio
-
Black Rock Inc. New York, NY14.5MShares$2.13 Billion0.08% of portfolio
-
State Street Corp Boston, MA7.34MShares$1.07 Billion0.06% of portfolio
-
Jpmorgan Chase & CO New York, NY5.26MShares$769 Million0.08% of portfolio
About BIOGEN INC.
- Ticker BIIB
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 144,000,992
- Market Cap $21.1B
- Description
- Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...